These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Persistence of Bacteriophage Phi 6 on Porous and Nonporous Surfaces and the Potential for Its Use as an Ebola Virus or Coronavirus Surrogate. Whitworth C; Mu Y; Houston H; Martinez-Smith M; Noble-Wang J; Coulliette-Salmond A; Rose L Appl Environ Microbiol; 2020 Aug; 86(17):. PubMed ID: 32591388 [TBL] [Abstract][Full Text] [Related]
7. Immune correlates of protection for SARS-CoV-2, Ebola and Nipah virus infection. Escudero-Pérez B; Lawrence P; Castillo-Olivares J Front Immunol; 2023; 14():1156758. PubMed ID: 37153606 [TBL] [Abstract][Full Text] [Related]
8. Validating the Inactivation Effectiveness of Chemicals on Ebola Virus. Haddock E; Feldmann F Methods Mol Biol; 2017; 1628():251-257. PubMed ID: 28573626 [TBL] [Abstract][Full Text] [Related]
9. Inactivation of SARS-CoV-2 in Serum Using Physical Methods. Harada T; Fujimoto H; Fukushi S; Ishii K; Hanaki KI Jpn J Infect Dis; 2024 Jul; 77(4):201-204. PubMed ID: 38296541 [TBL] [Abstract][Full Text] [Related]
10. Quantitative evaluation of SARS-CoV-2 inactivation using a deep ultraviolet light-emitting diode. Minamikawa T; Koma T; Suzuki A; Mizuno T; Nagamatsu K; Arimochi H; Tsuchiya K; Matsuoka K; Yasui T; Yasutomo K; Nomaguchi M Sci Rep; 2021 Mar; 11(1):5070. PubMed ID: 33658595 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings. Widera M; Westhaus S; Rabenau HF; Hoehl S; Bojkova D; Cinatl J; Ciesek S Med Microbiol Immunol; 2021 Aug; 210(4):235-244. PubMed ID: 34196781 [TBL] [Abstract][Full Text] [Related]
12. Magnetic biosensors for identification of SARS-CoV-2, Influenza, HIV, and Ebola viruses: a review. GhaderiShekhiAbadi P; Irani M; Noorisepehr M; Maleki A Nanotechnology; 2023 Apr; 34(27):. PubMed ID: 36996779 [TBL] [Abstract][Full Text] [Related]
13. Sphingosine Kinases Promote Ebola Virus Infection and Can Be Targeted to Inhibit Filoviruses, Coronaviruses, and Arenaviruses Using Late Endocytic Trafficking to Enter Cells. Stewart CM; Bo Y; Fu K; Chan M; Kozak R; Apperley KY; Laroche G; Daniel R; Beauchemin AM; Kobinger G; Kobasa D; Côté M ACS Infect Dis; 2023 May; 9(5):1064-1077. PubMed ID: 37053583 [TBL] [Abstract][Full Text] [Related]
14. Application of pseudotyped virus particles to monitor Ebola virus and SARS-CoV-2 viral entry in human cell lines. Eichler M; Aksi E; Pfeilschifter J; Imre G STAR Protoc; 2021 Dec; 2(4):100818. PubMed ID: 34467222 [TBL] [Abstract][Full Text] [Related]
15. Methylene blue photochemical treatment as a reliable SARS-CoV-2 plasma virus inactivation method for blood safety and convalescent plasma therapy for COVID-19. Jin C; Yu B; Zhang J; Wu H; Zhou X; Yao H; Liu F; Lu X; Cheng L; Jiang M; Wu N BMC Infect Dis; 2021 Apr; 21(1):357. PubMed ID: 33863281 [TBL] [Abstract][Full Text] [Related]
16. Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan Viruses. Holtsberg FW; Shulenin S; Vu H; Howell KA; Patel SJ; Gunn B; Karim M; Lai JR; Frei JC; Nyakatura EK; Zeitlin L; Douglas R; Fusco ML; Froude JW; Saphire EO; Herbert AS; Wirchnianski AS; Lear-Rooney CM; Alter G; Dye JM; Glass PJ; Warfield KL; Aman MJ J Virol; 2016 Jan; 90(1):266-78. PubMed ID: 26468533 [TBL] [Abstract][Full Text] [Related]
17. Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV). Zhou N; Pan T; Zhang J; Li Q; Zhang X; Bai C; Huang F; Peng T; Zhang J; Liu C; Tao L; Zhang H J Biol Chem; 2016 Apr; 291(17):9218-32. PubMed ID: 26953343 [TBL] [Abstract][Full Text] [Related]
18. Development and Testing of a Method for Validating Chemical Inactivation of Ebola Virus. Alfson KJ; Griffiths A Viruses; 2018 Mar; 10(3):. PubMed ID: 29533988 [TBL] [Abstract][Full Text] [Related]
19. Inactivation of Ebola virus and Middle East respiratory syndrome coronavirus in platelet concentrates and plasma by ultraviolet C light and methylene blue plus visible light, respectively. Eickmann M; Gravemann U; Handke W; Tolksdorf F; Reichenberg S; Müller TH; Seltsam A Transfusion; 2018 Sep; 58(9):2202-2207. PubMed ID: 29732571 [TBL] [Abstract][Full Text] [Related]
20. Ultrafast-UV laser integrating cavity device for inactivation of SARS-CoV-2 and other viruses. Ambardar S; Howell MC; Mayilsamy K; McGill A; Green R; Mohapatra S; Voronine DV; Mohapatra SS Sci Rep; 2022 Jul; 12(1):11935. PubMed ID: 35831374 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]